Health Care/Hospital

Akeso Announced 2023 Interim Results: First Profit, Growing Sales of PD-1/CTLA-4 Bispecific Antibody and Priority Review of PD-1/VEGF

—During the reporting period, Akeso's revenue was RMB3,676.9 million, an increase of 2,154.4% from 2022H1; Akeso recorded a profit ofRMB2,489.5 million. —RMB2,915.2 million was recognized by Akeso as license fee income during the reporting period due to the receipt of an upfront payment equivalen...

2023-08-30 08:03 2061

Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development

SHANGHAI, Aug. 29, 2023 /PRNewswire/ -- Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy utilizing epigenome regulation to treat prevalent diseases, today announced that it has raised$32 million in Series A round of financing c...

2023-08-30 08:00 3405

Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023

* Data from the pilot study in infantile spasms showed positive outcomes. * The results will be presented by Cerecin's Chief Medical Officer, Dr. Marc Cantillon on Sunday 2nd September at 2pm (GMT+1). * The Cerecin team will be accompanied by PharmaVentures, who will be supporting Cerecin's ...

2023-08-30 00:04 1499

Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023

* Data from the pilot study in infantile spasms showed positive outcomes. * The results will be presented by Cerecin's Chief Medical Officer, Dr. Marc Cantillon on Sunday 2nd September at 2pm (GMT+1). * The Cerecin team will be accompanied by PharmaVentures, who will be supporting Cerecin's ...

2023-08-30 00:02 1097

Viva Biotech (1873.HK) Announces 2023 Interim Results:Solid Growth in Main Business, Significant Rebound in Profitability

Highlights of the Interim Results as of June 30, 2023: * Revenue reached RMB1,142.2 million, representing a year-on-year increase of approximately 3.0% * Gross profit amounted to RMB406.0 million, representing a year-on-year increase of approximately 17.7% * Adjusted Non-IFRS net profit amo...

2023-08-29 22:38 2219

Datasea Announces Strategic Partnership with Sales and Marketing Firm for the Launch of Intelligent Acoustic Skin Repair Robot

BEIJING, Aug. 29, 2023 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), a digital technology corporation engaged in converging and innovative business segment for intelligent acoustics technology inChina today announced that Shuhai Information Technology Co., Ltd. ("Shuh...

2023-08-29 21:57 1647

Akeso Announced Completion of Patient Enrollment in Phase 3 Trial of Ivonescimab (PD-1/VEGF) versus Pembrolizumab in First-line PD-L1 Positive Advanced NSCLC

HONG KONG, Aug. 29, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", 9926. HK) announced completion of patient enrollment in a head-to-head study of ivonescimab (AK112, PD-1/VEGF bispecific antibody) compared with pembrolizumab as first-line treatment for patients with PD-L1 positive (PD-L1 TPS≥1%) loca...

2023-08-29 20:00 1152

Bayer Launches Stunting Prevention Program "CETING" for Community of Cisalak, Depok

DEPOK, Indonesia, Aug. 29, 2023 /PRNewswire/ -- Bayer, a global Life Science company in health and nutrition, is taking an active role in addressing the stunting problem inIndonesia. Coinciding with Bayer's 66th year in Indonesia, Bayer launched the CETING (Prevent Stunting) program for the commu...

2023-08-29 13:53 1702

A World's First: The Miss Hong Kong Pageant 2023 Unveiled Contestants' CircleDNA Results Live on Television

* Miss Hong Kong Pageant 2023 winner is Hilary Chong (no. 15) HONG KONG, Aug. 29, 2023 /PRNewswire/ -- In a move that had never been seen before, marrying beauty with science, the Miss Hong Kong Pageant 2023, which justaired on TVB, had set out to revolutionize the industry by partnering with C...

2023-08-29 12:46 1725

OTC Hearing Aids Ceretone Bags over $300,000 on Indiegogo, Prepares for Official Sale

ONTARIO, Calif., Aug. 29, 2023 /PRNewswire/ -- Ceretone , a brand under Audicon and a pioneer in the field of Over-the-Counter (OTC) hearing aids, is thrilled to announce the success of its Core One launch campaign on Indiegogo. T...

2023-08-29 09:51 1598

Kelun-Biotech Announces Interim Results for 2023: Global Strategic Partnership and Rich Pipeline Boost Significant Revenue Growth in the First Half of the Year

CHENGDU, China, Aug. 28, 2023 /PRNewswire/ -- Today, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990.HK), an innovative biopharmaceutical company focusing on the R&D, manufacturing, commercialization, and international cooperation of biotechnology drugs and innovat...

2023-08-28 22:56 3294

Global Times: GT on the spot: An unforgettable record of PLA naval hospital ship's weeklong visit to Solomon Islands

BEIJING, Aug. 28, 2023 /PRNewswire/ -- With groups of people waving goodbye, China's naval hospital ship the Ark Peace sailed from Honiara Harbor on Saturday morning after it successfully concluded its weeklong visit and dispensing medical services to theSolomon Islands. Similar to its arrival, ...

2023-08-28 21:21 1597

Navigating the Future of Neurosurgery: Brain Navi demonstrates NaoTrac and KrystoLens at CNS 2023 & EANS 2023

HSINCHU, Aug. 28, 2023 /PRNewswire/ -- Brain Navi announced today the demonstration of NaoTrac, a neurosurgical navigation robot and KrystoLens, a single-use neuro-endoscope at CNS 2023 inWashington D.C. and EANS 2023 in Barcelona, respectively.

2023-08-28 21:00 1516

ProfoundBio to Participate in the 21st Annual Morgan Stanley Conference

SEATTLE, Aug. 28, 2023 /PRNewswire/ -- ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-drug conjugate therapeutics for cancer, announced that management will be participating in one-on-one meetings at the Morgan Stanley 21st Annual Global Healthca...

2023-08-28 20:00 1031

Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines

The 2023 European Society of Cardiology (ESC) guidelines for acute and chronic heart failure (HF) include upgraded recommendations for intravenous (IV) iron supplementation, including Ferinject® (ferric carboxymaltose), for the management of iron deficiency in patients with HF. Phase IV HEART-FI...

2023-08-28 19:00 1995

3B Scientific acquires iNNOGING Medical

HAMBURG, Germany, Aug. 28, 2023 /PRNewswire/ -- 3B Scientific, a leading manufacturer and marketer of medical simulation products and anatomical models for healthcare education, announces today that it has reached an agreement to acquire iNNOGING Medical. iNNOGING Medical has developed the pione...

2023-08-28 17:13 1766

Harbour BioMed Announces 2023 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2023 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology an...

2023-08-28 17:08 2206

Meet Kuushy: Sit your way to better health

The smart cushion is paired with an AI-enabled Posture Coach that provides personalised prompts for users to adjust and correct their posture effectively SINGAPORE, Aug. 28, 2023 /PRNewswire/ -- Poor posture can lead to a whole range of problems – from neck and back pains to even heartburn and co...

2023-08-28 16:46 1242

Asia Pacific Enterprise Awards 2023 Thailand Paves the Way for a Resurgent Asia

BANGKOK, Aug. 28, 2023 /PRNewswire/ -- Enterprise Asia is pleased to honor the trailblazing business leaders and enterprises inThailand for pioneering the country's growth in the post-pandemic era at the Asia Pacific Enterprise Awards (APEA) 2023. Organized annually in 16 markets by regional NGO ...

2023-08-28 16:32 2295

Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2023 /PRNewswire/ -- Harbour BioMed (the"Company", HKEX: 02142) announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application to commence clinical trials of its first antib...

2023-08-28 16:30 1230
1 ... 105106107108109110111 ... 807